MultiOmic

Multiomic is a next-generation precision medicine business, applying computational systems biology to develop and commercialize data assets for metabolic syndrome — the world’s largest healthcare burden. With our unique combination of data science and biology expertise, we are enabling data-driven development of therapeutics and are bringing understanding into complex biological systems. Metabolic syndrome, a cluster of closely-related diseases (atherosclerotic cardiovascular disease, type 2 diabetes, chronic kidney disease, non-alcoholic fatty liver) with many common risk factors, is costing the healthcare system $2 trillion (forecast >$5.5 trillion by 2040).
MultiOmic colour logo
Founders / Management Robert Thong
Sectors Biotech
Located in London, United Kingdom
Co-Investors Hoxton Ventures, Ada Ventures, MMC Ventures, Fifty Years VC
Follow On

LinkedIn

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Sign up to receive our weekly newsletter and learn about investing in technologies that are changing the world.